Dr. Anna Kagan, MD

Dr. Kagan practices at Houston Medical Center ASC in Houston, Texas.

Dr. Kagan's NPI, 1689822579, was assigned on September 4, 2008. Dr. Kagan graduated from Albert Einstein College of Medicine in 2004. Dr. Kagan holds Texas license M6687.

Dr. Kagan's primary practice is Houston Medical Center ASC, at 6624 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (832) 680-4680.

Dr. Kagan's primary practice is Houston Medical Center ASC in Houston, Texas. Dr. Kagan is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Kagan to 4 more hospitals, 5 dialysis centers, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kagan practices, 14 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kagan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kagan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kagan is licensed in Texas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Kagan treats.

CMS data shows 5,780 Medicare services from Dr. Kagan across 13 procedure codes in 2024, for 860 Medicare patients. Medicare paid $455,700 for them.

CMS counts 860 Medicare patients who saw Dr. Kagan in 2024. The largest group is 65 to 74, with 348 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 4.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kagan's median patient age at 67, with 47% women.

In 2024, Dr. Kagan wrote 3,857 Medicare Part D claims for 463 patients. 90% of them were for generic drugs. CMS names the drug for 3,479 of them, across 66 drugs with 11 or more claims each, at $446,967 in total drug cost. In 2023, CMS named 3,049 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kagan for performance year 2024, reported as part of a group. Dr. Kagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kagan as offering telehealth.

Dmand AI links 18 papers to Dr. Kagan, published from 2001 to 2025. The most frequent topics are Cricetinae, Potassium Channels, Voltage-Gated and CHO Cells. Dr. Kagan has published most often in J Biol Chem. Dr. Kagan's most frequent co-authors are Thomas V. McDonald, MD, Richard J. Knight, MD and Yonathan F. Melman, MD, PhD.

CMS Open Payments shows 52 general payments to Dr. Kagan from 22 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 90% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $209.

Dmand AI lists 2 awards for Dr. Kagan, most recently CMS Stage 1 EHR in 2013.

Dr. Kagan graduated from Albert Einstein College of Medicine in 2004. Dr. Kagan is a member of ASN.

Dr. Kagan is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.